Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation

Patricia Devaux, Dale Christiansen, Marc Fontaine, Denis Gerlier

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

C3b and C5b deposition following complement activation, and its regulation by CD46 were studied using xenogenic Chinese hamster ovary (CHO) cells as targets and cytofluorometry. Following activation of the alternative pathway, an initial low level of C3b deposition was observed on CHO cell surfaces after a lag time of approximately 4 min. This was followed by a secondary high level of C3b deposition with a slower rate. C3b deposition was maximal within 15 min. When CD46 was expressed (B2 isoform), the kinetics of C3b deposition were essentially unchanged, but the onset of the secondary high C3b deposition was fully prevented. C5b deposition was also observed on CHO but not an CHO.CD46 cells following activation of the alternative pathway. Activation of the classical pathway on CHO and CHO.CD46 cells, using factor B-depleted human serum and anti-CHO antibodies, resulted in almost identical single-peak C3b deposition profiles. Accordingly, no regulation of C5b deposition by CD46 was evident following activation of the classical pathway. These data indicate that CD46 prevents the C3b deposition amplification loop mediated by the alternative C3 convertase and, consequently, inhibits the formation of the alternative C5 convertase. But CD46 prevents neither the spontaneous tick-over C3b deposition leading to the formation of the alternative C3 convertase nor the formation of the functional classical C3 and C5 convertases.

Original languageEnglish (US)
Pages (from-to)815-822
Number of pages8
JournalEuropean Journal of Immunology
Volume29
Issue number3
StatePublished - 1999
Externally publishedYes

Fingerprint

CD46 Antigens
Complement Activation
Cricetulus
Complement C3-C5 Convertases
Ovary
Classical Pathway Complement C5 Convertase
Classical Pathway Complement C3 Convertase
Ticks
Protein Isoforms
Antibodies

Keywords

  • Alternative pathway
  • C3b
  • CD46
  • Classical pathway
  • Complement

ASJC Scopus subject areas

  • Immunology

Cite this

Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation. / Devaux, Patricia; Christiansen, Dale; Fontaine, Marc; Gerlier, Denis.

In: European Journal of Immunology, Vol. 29, No. 3, 1999, p. 815-822.

Research output: Contribution to journalArticle

@article{1582dd1f4c304ae18c8277bf5d467993,
title = "Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation",
abstract = "C3b and C5b deposition following complement activation, and its regulation by CD46 were studied using xenogenic Chinese hamster ovary (CHO) cells as targets and cytofluorometry. Following activation of the alternative pathway, an initial low level of C3b deposition was observed on CHO cell surfaces after a lag time of approximately 4 min. This was followed by a secondary high level of C3b deposition with a slower rate. C3b deposition was maximal within 15 min. When CD46 was expressed (B2 isoform), the kinetics of C3b deposition were essentially unchanged, but the onset of the secondary high C3b deposition was fully prevented. C5b deposition was also observed on CHO but not an CHO.CD46 cells following activation of the alternative pathway. Activation of the classical pathway on CHO and CHO.CD46 cells, using factor B-depleted human serum and anti-CHO antibodies, resulted in almost identical single-peak C3b deposition profiles. Accordingly, no regulation of C5b deposition by CD46 was evident following activation of the classical pathway. These data indicate that CD46 prevents the C3b deposition amplification loop mediated by the alternative C3 convertase and, consequently, inhibits the formation of the alternative C5 convertase. But CD46 prevents neither the spontaneous tick-over C3b deposition leading to the formation of the alternative C3 convertase nor the formation of the functional classical C3 and C5 convertases.",
keywords = "Alternative pathway, C3b, CD46, Classical pathway, Complement",
author = "Patricia Devaux and Dale Christiansen and Marc Fontaine and Denis Gerlier",
year = "1999",
language = "English (US)",
volume = "29",
pages = "815--822",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "3",

}

TY - JOUR

T1 - Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation

AU - Devaux, Patricia

AU - Christiansen, Dale

AU - Fontaine, Marc

AU - Gerlier, Denis

PY - 1999

Y1 - 1999

N2 - C3b and C5b deposition following complement activation, and its regulation by CD46 were studied using xenogenic Chinese hamster ovary (CHO) cells as targets and cytofluorometry. Following activation of the alternative pathway, an initial low level of C3b deposition was observed on CHO cell surfaces after a lag time of approximately 4 min. This was followed by a secondary high level of C3b deposition with a slower rate. C3b deposition was maximal within 15 min. When CD46 was expressed (B2 isoform), the kinetics of C3b deposition were essentially unchanged, but the onset of the secondary high C3b deposition was fully prevented. C5b deposition was also observed on CHO but not an CHO.CD46 cells following activation of the alternative pathway. Activation of the classical pathway on CHO and CHO.CD46 cells, using factor B-depleted human serum and anti-CHO antibodies, resulted in almost identical single-peak C3b deposition profiles. Accordingly, no regulation of C5b deposition by CD46 was evident following activation of the classical pathway. These data indicate that CD46 prevents the C3b deposition amplification loop mediated by the alternative C3 convertase and, consequently, inhibits the formation of the alternative C5 convertase. But CD46 prevents neither the spontaneous tick-over C3b deposition leading to the formation of the alternative C3 convertase nor the formation of the functional classical C3 and C5 convertases.

AB - C3b and C5b deposition following complement activation, and its regulation by CD46 were studied using xenogenic Chinese hamster ovary (CHO) cells as targets and cytofluorometry. Following activation of the alternative pathway, an initial low level of C3b deposition was observed on CHO cell surfaces after a lag time of approximately 4 min. This was followed by a secondary high level of C3b deposition with a slower rate. C3b deposition was maximal within 15 min. When CD46 was expressed (B2 isoform), the kinetics of C3b deposition were essentially unchanged, but the onset of the secondary high C3b deposition was fully prevented. C5b deposition was also observed on CHO but not an CHO.CD46 cells following activation of the alternative pathway. Activation of the classical pathway on CHO and CHO.CD46 cells, using factor B-depleted human serum and anti-CHO antibodies, resulted in almost identical single-peak C3b deposition profiles. Accordingly, no regulation of C5b deposition by CD46 was evident following activation of the classical pathway. These data indicate that CD46 prevents the C3b deposition amplification loop mediated by the alternative C3 convertase and, consequently, inhibits the formation of the alternative C5 convertase. But CD46 prevents neither the spontaneous tick-over C3b deposition leading to the formation of the alternative C3 convertase nor the formation of the functional classical C3 and C5 convertases.

KW - Alternative pathway

KW - C3b

KW - CD46

KW - Classical pathway

KW - Complement

UR - http://www.scopus.com/inward/record.url?scp=0033053789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033053789&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 815

EP - 822

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 3

ER -